• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

La Jolla Pharmaceutical Co

+ Add to Watchlist

LJPC:US

11.2500 USD 1.0500 10.29%

As of 20:10:00 ET on 10/24/2014.

Snapshot for La Jolla Pharmaceutical Co (LJPC)

Open: 10.5500 Day's Range: 10.4500 - 11.4800 Volume: 369,592
Previous Close: 10.2000 52wk Range: 5.5000 - 19.5000 1-Yr Rtn: +19.05%

Stock Chart for LJPC

No chart data available.
  • LJPC:US 11.2500
  • 1D
  • 1M
  • 1Y
10.2000
Interactive LJPC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LJPC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -21.1399
Est. EPS (USD) (12/2014) -1.7670
Est. PEG Ratio -
Market Cap (M USD) 171.37
Shares Outstanding (M) 15.23
30 Day Average Volume 133,075
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LJPC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LJPC

La Jolla Pharmaceutical Company researches and develops specialized therapeutics for the treatment of diseases caused by antibodies. The Company is developing products to treat autoimmune conditions such as lupus and antibody-mediated stroke.

George F TidmarshPresident/CEO/SecretaryChester S Zygmont IIISenior Dir:Finance
James RolkeSenior Dir:Research & Dev
More Company Profile & Key Executives for LJPC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil